Fox Chase Cancer Center News

Temple Health and Fox Chase Cancer Center Researchers Reveal the Importance of Three Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

PHILADELPHIA (May 30, 2023)—Patients with muscle-invasive bladder cancer who receive fewer than three cycles of chemotherapy prior to bladder removal surgery face higher risk of recurrence and worse survival outcomes. That’s according to research from Temple Health and Fox Chase Cancer Center that will be presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.

Temple-Led NCI-Funded Partnership Holds Fifth Annual Showcase

PHILADELPHIA (May 24, 2023)— “SPEECH amplifies fundamental purposes at Temple’s core: Inclusive, accessible excellence in research, education, workforce development, and community engagement,” said JoAnne Epps, Acting Temple University President, during last week’s exciting gathering at the Lewis Katz School of Medicine.